Last reviewed · How we verify
Turmeric
At a glance
| Generic name | Turmeric |
|---|---|
| Also known as | Medicaments for non-vital pulpotomy procedure |
| Sponsor | Shiraz University of Medical Sciences |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- The Assessment of Curcuma Longa Potentials for Soft and Hard Tissue Healing in Fresh (PHASE1)
- Effect of a Multidomain Intervention Plus Turmeric on the Prevention of Cognitive Decline in People Over 55 Years of Age With Insulin Resistance. (PHASE2, PHASE3)
- Adjuvant Curcumin to Assess Recurrence Free Survival in Patients Who Have Had a Radical Prostatectomy (PHASE3)
- Study of the Safety and Usefulness of Liposomal Curcumin in Multiple Myeloma (PHASE1)
- Curcumin in Critically Ill Patients With Sepsis (NA)
- Effectiveness and Safety of Benemix® in Constipation (NA)
- Curcumin in Combination With 5FU for Colon Cancer (EARLY_PHASE1)
- Effect of Nutritional Supplementation With Turmeric on the Cognitive Performance of Subjects With Metabolic Syndrome (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Turmeric CI brief — competitive landscape report
- Turmeric updates RSS · CI watch RSS
- Shiraz University of Medical Sciences portfolio CI